Vasculitis

Phil Seo, M.D.

Abstract 1265:  Repeated Use of Rituximab in Refractory Wegener’s Granulomatosis: Efficacy for Glucocorticoid-Free Remission Maintenance

Abstract 2130:  Antineutrophil Cytoplasmic Antibodies against Proteinase 3 Do Not Predict Disease Relapses in Wegener’s Granulomatosis

Abstract 439:  Adjunctive Methotrexate to Treat Giant Cell Arteritis: An Individual Patient Data Meta-Analysis

Abstract 2126:  Incidence and Pevalence of Wegener’s Granulomatosis, Microscopic Polyangiitis, and the Churg-Strauss syndrome in southern Sweden

Abstract 1266:  Polyarteritis nodosa (PAN): Clinical description and long-term outcome of the 351 patients from the French Vasculitis Study Group

Abstract 1168:  Takayasu Arteritis: Guarded outcomes in an American Cohort

All information contained within the Johns Hopkins Arthritis Center website is intended for educational purposes only. Physicians and other health care professionals are encouraged to consult other sources and confirm the information contained within this site. Consumers should never disregard medical advice or delay in seeking it because of something they may have read on this website.

• Rheumatoid Arthritis
• Treatment Strategies
• TNF Antagonists
• B-Cell Depletion
• Other Agents
• OA Clinical Aspects
• Juvenile RA / Pediatric Rheumatology
• Systemic Lupus Erythematosus
• Vasculitis
• Scleroderma
• Fibromyalgia
• Spondyloarthropathies
• Myositis
• Pregnancy in AutoImmune Disease
• Non-Pharmacologic Management
• Basic Science
• Epidemiology
• Psychosocial